Low galactosylation of IgG associates with higher risk for future diagnosis of rheumatoid arthritis during 10 years of follow-up

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1864, Issue 6, 2018, Pages 2034-2039

  Gudelj, Ivan ^a   Salo, Perttu P ^b,c   Trbojević Akmačić, Irena ^a   Albers, Malena ^a   Primorac, Dragan ^a,d,e,f,g,h   Perola, Markus ^b,c,i   Lauc, Gordan ^a,j  

^a GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d St Catherine Specialty Hospital   (Croatia)

^e JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^f UNIVERSITY OF SPLIT   (Croatia)

^g PENNSYLVANIA STATE UNIVERSITY   (United States)

^h SREBRNJAK CHILDREN S HOSPITAL   (Croatia)

ⁱ UNIVERSITY OF TARTU   (Estonia)

^j UNIVERSITY OF ZAGREB   (Croatia)

more..

Author keywords

Biomarker; Immunoglobulin G; N glycans; Rheumatoid arthritis; Risk factor

Indexed keywords

GLYCAN; IMMUNOGLOBULIN G; AUTOANTIBODY; GLYCOSYLATED IGG; POLYSACCHARIDE;

ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GALACTOSYLATION; GLYCOSYLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIALYLATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ADULT; AGED; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; INCIDENCE; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; MALE; MIDDLE AGED; POLYSACCHARIDES; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 85055862281     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2018.03.018     Document Type: Article

References (49)

1. Silman, A.J., Pearson, J.E., Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 4:Suppl. 3 (2002), S265–72, 10.1186/ar578.
2. Smolen, J.S., Aletaha, D., McInnes, I.B., Rheumatoid arthritis. Lancet 388 (2016), 2023–2038, 10.1016/S0140-6736(16)30173-8.
3. Aletaha, D., Alasti, F., Smolen, J.S., Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials. Arthritis Res. Ther., 17, 2015, 229, 10.1186/s13075-015-0736-9.
4. Gonzalez, A., Icen, M., Kremers, H.M., Crowson, C.S., Davis, J.M., Therneau, T.M., Roger, V.L., Gabriel, S.E., Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J. Rheumatol. 35 (2008), 1009–1014, 10.1016/j.molcel.2007.05.041.A.
5. Smolen, J.S., Landewé R., Breedveld, F.C., Dougados, M., Emery, P., Gaujoux-Viala, C., Gorter, S., Knevel, R., Nam, J., Schoels, M., Aletaha, D., Buch, M., Gossec, L., Huizinga, T., Bijlsma, J.W.J.W., Burmester, G., Combe, B., Cutolo, M., Gabay, C., Gomez-Reino, J., Kouloumas, M., Kvien, T.K., Martin-Mola, E., McInnes, I., Pavelka, K., van Riel, P., Scholte, M., Scott, D.L., Sokka, T., Valesini, G., van Vollenhoven, R., Winthrop, K.L., Wong, J., Zink, A., van der Heijde, D., EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann. Rheum. Dis. 69 (2010), 964–975, 10.1136/ard.2009.126532.
6. Bondt, A., Rombouts, Y., Selman, M.H.J., Hensbergen, P.J., Reiding, K.R., Hazes, J.M.W., Dolhain, R.J.E.M., Wuhrer, M., Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes. Mol. Cell. Proteomics 13 (2014), 3029–3039, 10.1074/mcp.M114.039537.
7. Pucic, M., Knezevic, A., Vidic, J., Adamczyk, B., Novokmet, M., Polasek, O., Gornik, O., Supraha-Goreta, S., Wormald, M.R., Redzic, I., Campbell, H., Wright, A., Hastie, N.D., Wilson, J.F., Rudan, I., Wuhrer, M., Rudd, P.M., Josic, D., Lauc, G., High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol. Cell. Proteomics, 10, 2011, 10.1074/mcp.M111.010090.
8. Parekh, R.B., Dwek, R.A., Sutton, B.J., Fernandes, D.L., Leung, A., Stanworth, D., Rademacher, T.W., Mizuochi, T., Taniguchi, T., Matsuta, K., Takeuchi, F., Nagano, Y., Miyamoto, T., Kobata, A., Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316 (1985), 452–457, 10.1038/316452a0.
9. Bondt, A., Selman, M.H.J., Deelder, A.M., Hazes, J.M.W., Willemsen, S.P., Wuhrer, M., Dolhain, R.J.E.M., Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation. J. Proteome Res. 12 (2013), 4522–4531, 10.1021/pr400589m.
10. van de Geijn, F.E., Wuhrer, M., Selman, M.H., Willemsen, S.P., de Man, Y. a, Deelder, A.M., Hazes, J.M., Dolhain, R.J., Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study. Arthritis Res. Ther., 11, 2009, R193, 10.1186/ar2892.
11. Alavi, A., Arden, N., Spector, T.D., Axford, J.S., Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy. J. Rheumatol. 27 (2000), 1379–1385.
12. Pasek, M., Duk, M., Podbielska, M., Sokolik, R., Szechiński, J., Lisowska, E., Krotkiewski, H., Galactosylation of IgG from rheumatoid arthritis (RA) patients - changes during therapy. Glycoconj. J. 23 (2006), 463–471, 10.1007/s10719-006-5409-0.
13. Saldova, R., Huffman, J.E., Adamczyk, B., Mužinić A., Kattla, J.J., Pučić M., Novokmet, M., Abrahams, J.L., Hayward, C., Rudan, I., Wild, S.H., Wright, A.F., Polašek, O., Lauc, G., Campbell, H., Wilson, J.F., Rudd, P.M., Association of medication with the human plasma N-glycome. J. Proteome Res., 2012, 1821–1831, 10.1021/pr2010605.
14. Croce, A., Firuzi, O., Altieri, F., Eufemi, M., Agostino, R., Priori, R., Bombardieri, M., Alessandri, C., Valesini, G., Saso, L., Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis. J. Clin. Lab. Anal. 21 (2007), 303–314, 10.1002/jcla.20191.
15. Gińdzieńska-Sieśkiewicz, E., Radziejewska, I., Domysławska, I., Klimiuk, P.A., Sulik, A., Rojewska, J., Gabryel-Porowska, H., Sierakowski, S., Changes of glycosylation of IgG in rheumatoid arthritis patients treated with methotrexate. Adv. Med. Sci. 61 (2016), 193–197, 10.1016/j.advms.2015.12.009.
16. Albrecht, S., Unwin, L., Muniyappa, M., Rudd, P.M., Glycosylation as a marker for inflammatory arthritis. Cancer Biomark. 14 (2014), 17–28, 10.3233/CBM-130373.
17. Vučković F., Krištić J., Gudelj, I., Teruel Artacho, M., Keser, T., Pezer, M., Pučić-Baković M., Štambuk, J., Trbojević-Akmačić I., Barrios, C., Pavić T., Menni, C., Wang, Y., Zhou, Y., Cui, L., Song, H., Zeng, Q., Guo, X., Pons-Estel, B.A., McKeigue, P., Patrick, A.L., Gornik, O., Spector, T.D., Harjaček, M., Alarcon-Riquelme, M., Molokhia, M., Wang, W., Lauc, G., Systemic lupus erythematosus associates with the decreased immunosuppressive potential of the IgG glycome. Arthritis Rheum. 67 (2015), 2978–2989 (Hoboken, N.J.) https://doi.org/10.1002/art.39273.
18. Trbojević Akmačić I., Ventham, N.T., Theodoratou, E., Vučković F., Kennedy, N.A., Krištić J., Nimmo, E.R., Kalla, R., Drummond, H., Štambuk, J., Dunlop, M.G., Novokmet, M., Aulchenko, Y., Gornik, O., Campbell, H., Pučić Baković M., Satsangi, J., Lauc, G., IBD-BIOM Consortium, Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome. Inflamm. Bowel Dis. 21 (2015), 1237–1247, 10.1097/MIB.0000000000000372.
19. Freidin, M.B., Keser, T., Gudelj, I., Štambuk, J., Vučenović D., Allegri, M., Pavić T., Šimurina, M., Fabiane, S.M., Lauc, G., Williams, F.M.K., The association between low back pain and composition of IgG glycome. Nat. Publ. Group, 2016, 1–11, 10.1038/srep26815.
20. Barrios, C., Zierer, J., Gudelj, I., Stambuk, J., Ugrina, I., Rodriguez, E., Soler, M.J., Pavic, T., Simurina, M., Keser, T., Pucic-Bakovic, M., Mangino, M., Pascual, J., Spector, T.D., Lauc, G., Menni, C., Glycosylation profile of IgG in moderate kidney dysfunction. J. Am. Soc. Nephrol., 2015, 1–9, 10.1681/ASN.2015010109.
21. Gudelj, I., Baciarello, M., Ugrina, I., De Gregori, M., Napolioni, V., Ingelmo, P.M., Bugada, D., De Gregori, S., Đerek, L., Pučić-Baković M., Novokmet, M., Gornik, O., Saccani Jotti, G., Meschi, T., Lauc, G., Allegri, M., Changes in total plasma and serum N-glycome composition and patient-controlled analgesia after major abdominal surgery. Sci. Rep., 6, 2016, 31234, 10.1038/srep31234.
22. Watson, M., Rudd, P.M., Bland, M., Dwek, R.A., Axford, J.S., Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides. Arthritis Rheum. 42 (1999), 1682–1690, 10.1002/1529-0131(199908)42:8<1682::AID-ANR17>3.0.CO;2-X.
23. Tsuchiya, N., Endo, T., Yoshinoya, S., Nagano, Y., Shiota, M., Furukawa, K., Kobatat, A., Detection of glycosylation abnormality in rheumatoid. J. Immunol. 151 (1993), 1137–1146.
24. Yarwood, A., Viatte, S., Okada, Y., Plenge, R., Yamamoto, K., Barton, A., Symmons, D., Raychaudhuri, S., Klareskog, L., Gregersen, P., Worthington, J., Eyre, S., Loci associated with N-glycosylation of human IgG are not associated with rheumatoid arthritis: a Mendelian randomisation study. Ann. Rheum. Dis. 75 (2016), 317–320, 10.1136/annrheumdis-2014-207210.
25. Trbojević-Akmačić I., Ugrina, I., Lauc, G., Comparative analysis and validation of different steps in glycomics studies. Methods Enzymol. 586 (2016), 37–55, 10.1016/bs.mie.2016.09.027.
26. Baković M.P., Selman, M.H.J., Hoffmann, M., Rudan, I., Campbell, H., Deelder, A.M., Lauc, G., Wuhrer, M., High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides. J. Proteome Res. 12 (2013), 821–831, 10.1021/pr300887z.
27. Trbojević Akmačić I., Ugrina, I., Štambuk, J., Gudelj, I., Vučković F., Lauc, G., Pučić-Baković M., High-throughput glycomics: optimization of sample preparation. Biochemist 80 (2015), 934–942, 10.1134/S0006297915070123.
28. Borodulin, K., Vartiainen, E., Peltonen, M., Jousilahti, P., Juolevi, A., Laatikainen, T., Mannisto, S., Salomaa, V., Sundvall, J., Puska, P., Forty-year trends in cardiovascular risk factors in Finland. Eur. J. Pub. Health 25 (2015), 539–546, 10.1093/eurpub/cku174.
29. Mastrangelo, A., Colasanti, T., Barbati, C., Pecani, A., Sabatinelli, D., Pendolino, M., Truglia, S., Massaro, L., Mancini, R., Miranda, F., Spinelli, F.R., Conti, F., Alessandri, C., The role of posttranslational protein modifications in rheumatological diseases: focus on rheumatoid arthritis. J Immunol Res, 2015, 2015, 10.1155/2015/712490.
30. Parekh, R.B., Isenberg, D.A., Ansell, B.M., Roitt, I.M., Dwek, R.A., Rademacher, T.W., Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet 331 (1988), 966–969, 10.1016/S0140-6736(88)91781-3.
31. Young, A., Sumar, N., Bodman, K., Goyal, S., Sinclair, H., Roitt, I., Isenberg, D., Agalactosyl IgG: an aid to differential diagnosis in early synovitis. Arthritis Rheum. 34 (1991), 1425–1429.
32. Axford, J.S., Sumar, N., Alavi, A., Isenberg, D.A., Young, A., Bodman, K.B., Roitt, I.M., Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. J. Clin. Invest. 89 (1992), 1021–1031, 10.1172/JCI115643.
33. Gindzienska-Sieskiewicz, E., Klimiuk, P.A., Kisiel, D.G., Gindzienski, A., Sierakowski, S., The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis. Clin. Rheumatol. 26 (2007), 685–690, 10.1007/s10067-006-0370-7.
34. Pekelharing, J.M., Hepp, E., Kamerling, J.P., Gerwig, G.J., Leijnse, B., Alterations in carbohydrate composition of serum IgG from patients with rheumatoid arthritis and from pregnant women. Ann. Rheum. Dis. 47 (1988), 91–95, 10.1136/ard.47.2.91.
35. Pilkington, C., Yeung, E., Isenberg, D., Lefvert, A.K., Rook, G.A.W., Agalactosyl igg and antibody specificity in rheumatoid arthritis, tuberculosis, systemic lupus erythematosus and myasthenia gravis. Autoimmunity 22 (1995), 107–111, 10.3109/08916939508995306.
36. Bond, A., Alavi, A., Axford, J.S., Youinou, P., Hay, F.C., The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjögren's syndrome (SS). Clin. Exp. Immunol. 105 (1996), 99–103, 10.1046/j.1365-2249.1996.d01-741.x.
37. Pfeifle, R., Rothe, T., Ipseiz, N., Scherer, H.U., Culemann, S., Harre, U., Ackermann, J.A., Seefried, M., Kleyer, A., Uderhardt, S., Haugg, B., Hueber, A.J., Daum, P., Heidkamp, G.F., Ge, C., Böhm, S., Lux, A., Schuh, W., Magorivska, I., Nandakumar, K.S., Lönnblom, E., Becker, C., Dudziak, D., Wuhrer, M., Rombouts, Y., Koeleman, C.A., Toes, R., Winkler, T.H., Holmdahl, R., Herrmann, M., Blüml, S., Nimmerjahn, F., Schett, G., Krönke, G., Regulation of autoantibody activity by the IL-23-T H 17 axis determines the onset of autoimmune disease. Nat. Immunol. 18 (2017), 104–113, 10.1038/ni.3579.
38. Maverakis, E., Kim, K., Shimoda, M., Gershwin, M.E., Patel, F., Wilken, R., Raychaudhuri, S., Ruhaak, L.R., Lebrilla, C.B., Glycans in the immune system and the altered glycan theory of autoimmunity: a critical review. J. Autoimmun. 57 (2015), 1–13, 10.1016/j.jaut.2014.12.002.
39. Malhotra, R., Wormald, M.R., Rudd, P.M., Fischer, P.B., Dwek, R. a, Sim, R.B., Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat. Med. 1 (1995), 237–243, 10.1038/nm0395-237.
40. Banda, N.K., Wood, A.K., Takahashi, K., Levitt, B., Rudd, P.M., Royle, L., Abrahams, J.L., Stahl, G.L., Holers, V.M., Arend, W.P., Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies. Arthritis Rheum. 58 (2008), 3081–3089, 10.1002/art.23865.
41. Ercan, A., Cui, J., Chatterton, D.E.W., Deane, K.D., Hazen, M.M., Brintnell, W., O'Donnell, C.I., Derber, L.A., Weinblatt, M.E., Shadick, N.A., Bell, D.A., Cairns, E., Solomon, D.H., Holers, V.M., Rudd, P.M., Lee, D.M., Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum. 62 (2010), 2239–2248, 10.1002/art.27533.
42. Rombouts, Y., Ewing, E., van de Stadt, L. a, Selman, M.H.J., Trouw, L. a, Deelder, A.M., Huizinga, T.W.J., Wuhrer, M., van Schaardenburg, D., Toes, R.E.M., Scherer, H.U., Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann. Rheum. Dis. 74 (2015), 234–241, 10.1136/annrheumdis-2013-203565.
43. Gan, R.W., Trouw, L.A., Shi, J., Toes, R.E.M., Huizinga, T.W.J., Demoruelle, M.K., Kolfenbach, J.R., Zerbe, G.O., Deane, K.D., Edison, J.D., Gilliland, W.R., Norris, J.M., Holers, V.M., Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis. J. Rheumatol. 42 (2015), 572–579, 10.3899/jrheum.140767.
44. Paul, B.J., Kandy, H.I., Krishnan, V., Pre-rheumatoid arthritis and its prevention. Eur. J. Rheumatol. 4 (2017), 161–165, 10.5152/eurjrheum.2017.16006.
45. Tedeschi, S.K., Cui, J., Arkema, E.V., Robinson, W.H., Sokolove, J., Lingampalli, N., Sparks, J.A., Karlson, E.W., Costenbader, K.H., Elevated BMI and antibodies to citrullinated proteins interact to increase rheumatoid arthritis risk and shorten time to diagnosis: a nested case–control study of women in the Nurses’ Health Studies. Semin. Arthritis Rheum. 46 (2017), 692–698, 10.1016/j.semarthrit.2016.09.001.
46. Wahl, A., Kasela, S., Carnero-Montoro, E., van Iterson, M., Štambuk, J., Sharma, S., van den Akker, E., Klaric, L., Benedetti, E., Razdorov, G., Trbojević-Akmačić I., Vučković F., Ugrina, I., Beekman, M., Deelen, J., van Heemst, D., Heijmans, B.T., Consortium, B.I.O.S., Wuhrer, M., Plomp, R., Keser, T., Šimurina, M., Pavić T., Gudelj, I., Krištić J., Grallert, H., Kunze, S., Peters, A., Bell, J.T., Spector, T.D., Milani, L., Slagboom, P.E., Lauc, G., Gieger, C., IgG glycosylation and DNA methylation are interconnected with smoking. Biochim. Biophys. Acta, Gen. Subj. 1862 (2018), 637–648, 10.1016/j.bbagen.2017.10.012.
47. Sparks, J.A., Iversen, M.D., Miller Kroouze, R., Mahmoud, T.G., Triedman, N.A., Kalia, S.S., Atkinson, M.L., Lu, B., Deane, K.D., Costenbader, K.H., Green, R.C., Karlson, E.W., Personalized risk estimator for rheumatoid arthritis (PRE-RA) family study: rationale and design for a randomized controlled trial evaluating rheumatoid arthritis risk education to first-degree relatives. Contemp. Clin. Trials. 39 (2014), 145–157, 10.1016/j.cct.2014.08.007.
48. Rantapää-Dahlqvist, S., De Jong, B.A.W., Berglin, E., Hallmans, G., Wadell, G., Stenlund, H., Sundin, U., Van Venrooij, W.J., Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 48 (2003), 2741–2749, 10.1002/art.11223.
49. Ercan, A., Kohrt, W.M., Cui, J., Deane, K.D., Pezer, M., Yu, E.W., Hausmann, J.S., Campbell, H., Kaiser, U.B., Rudd, P.M., Lauc, G., Wilson, J.F., Finkelstein, J.S., Nigrovic, P.A., Estrogens regulate glycosylation of IgG in women and men. JCI Insight 2 (2017), 1–9, 10.1172/jci.insight.89703.